Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT02322892
The main purpose of this pilot study is to test the effects of thiamine (vitamin B1) administration before and after major cardiac surgery. Half of patients will receive thiamine and the other half will receive placebo.
The investigators' main hypothesis is that thiamine will improve cellular oxygen consumption and lead to decreased levels of post-operative lactate levels and ultimately improved patient outcomes.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02215, United States
Over 230,000 patients in the United States undergo Coronary Artery Bypass Grafting (CABG) each year. While mortality is relatively low, morbidity remains substantial with a significant risk of prolonged time on mechanical ventilation, prolonged length of hospital and intensive care unit stay and many other complications. CABG causes a profound stress response and significant metabolic alterations occur, including a shift from aerobic to anaerobic metabolism, causing increased levels of pyruvate and lactate. Elevated lactate, a marker of anaerobic metabolism, is a common and significant finding in patients after CABG and is correlated with increased mortality and morbidity.
Aerobic metabolism occurs when pyruvate enters the mitochondria through pyruvate decarboxylation to acetyl-Coenzyme A, facilitated by the enzyme pyruvate dehydrogenase (PDH). Decreased PDH activity may cause a shift toward anaerobic metabolism and play a role in the changes seen in patients undergoing CABG. Thiamine (vitamin B1) is a key co-factor for PDH function and will increase activity even in non-deficient states. The investigators hypothesize that thiamine administration will increase PDH activity in patients undergoing CABG, leading to increased cellular oxygen consumption, as represented by decreased lactate levels after surgery, and ultimately improved clinical outcomes.
In order to test the investigators' hypothesis and to obtain data for a large-scale clinical trial evaluating relevant clinical endpoints, the investigators are conducting a randomized, double-blind, pilot trial of thiamine in high-risk patients undergoing CABG.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)
Other names: vitamin B1, Thiamin
50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)
Time frame: Post-surgery within 1 hour of arrival to the ICU
Time frame: Post-surgery within 1 hour of arrival to the ICU
PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method. Reported as relative change from before the surgery.
Time frame: Until hospital discharge, limit 60 days
Atrial fibrillation, delirium, renal failure, stroke, myocardial infarction, acute respiratory distress syndrome, infection
Time frame: Until hospital discharge, limit 60 days
Duration of intensive care unit stay
Time frame: Until hospital discharge, limit 60 days
Time frame: Six hours after end of surgery surgery
Time frame: Six hours after end of surgery surgery
PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method
Time frame: Limit 60 days
Time frame: Limit 60 days
Time frame: From arrival to ICU to extubation, limit 6 hours
VO2 will be measured with a Compact Anesthesia monitor
Time frame: Post-surgery within 1 hour of arrival to the ICU
Cellular (peripheral blood mononuclear cells) oxygen consumption measured with the XFe24 Extracellular Flux Analyzers
Beth Israel Deaconess Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07027670
Aortic Valve Disease, Cardiac Surgical Procedures
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT07587307
Coronary Artery Bypass
Diyarbakır, Turkey (Türkiye)
View Trial DetailsNCT07470034
Cardiac Rehabilitation, Coronary Artery Bypass
Gaziantep, şehitkamil, Turkey (Türkiye)
View Trial DetailsNCT05726019
Acute Coronary Syndrome, Arterial Occlusive Diseases
São Paulo, Brazil
View Trial Details